Bristol-Myers to Buy Fibrosis Drug and its Developer

03.09.2015 - Bristol-Myers Squibb (BMS) will pay as much as $1.25 billion for the worldwide rights to a developing fibrosis drug as part of a deal that also gives it the right to buy the...